Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYO3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NENF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5J2-PTCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCDN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4800 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MALSU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R16B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC654342 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DNHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF598 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPARD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on